PLEURAL MESOTHELIOMA

This adverse event was reported 136 times

PLEURAL MESOTHELIOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FORMALDEHYDE 1 0.0164
1 ASPIRIN AND DIPYRIDAMOLE 1 0.0042
2 PORFIMER SODIUM 1 0.0029
3 INSULIN DEGLUDEC AND LIRAGLUTIDE 2 0.0012
4 LINAGLIPTIN AND METFORMIN HYDROCHLORIDE 1 0.0008
5 SITAGLIPTIN PHOSPHATE 2 0.0007
6 NADOLOL 2 0.0003
7 ACARBOSE 1 0.0003
8 EVEROLIMUS TABLETS 4 0.0002
9 PEMETREXED DISODIUM 8 0.0002
See all drugs enriched for association with PLEURAL MESOTHELIOMA